Anika Therapeutics, Inc. (ANIK) Insider Trading
Sector: Biotechnology · Market Cap: $199M · 0 insider purchases in the last 7 days
No open market insider purchases at Anika Therapeutics, Inc. in the last 7 days.
Want more?
Sign up free to see 30+ days of history, set alerts, and track ANIK on your watchlist.
Start for FreeAbout Anika Therapeutics, Inc. Insider Trading
2 insiders at Anika Therapeutics, Inc. (ANIK) have purchased stock in the past 90 days, totaling $223K across 2 transactions (17,200 shares).
The most recent purchase was by Director HENNEMAN JOHN B III on May 1, 2026 — a $73K buy of 5,000 shares at $14.66, bringing his total holdings to 54,871 shares.
Insiders who purchased: Griffin Stephen D. (CEO, 1 buy totaling $150K); HENNEMAN JOHN B III (Director, 1 buy totaling $73K).
This insider buying is notable given that ANIK had no recorded open market purchases in the nine months before that.
ANIK is in the Biotechnology sector within the Biotechnology industry with a market cap of $199M.
Track ANIK insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.